BridgeBio Neutral Stance From Citi Shakes ATTR-CM Outlook
Citi initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
Both vehicle types have fee trade-offs. This guide shows how expense ratios and additional costs stack up to help you pick the cheaper option.
28,162 articlesCiti initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
A leadership reshuffle at ICE has intensified scrutiny of the revolving door between private prison firms and federal...
A leading analyst signals more upside for CVS Health as Medicare-related momentum builds. Learn the key drivers, risk...
A $28 billion AI hardware IPO is trading at about 7x forward earnings, sparking a heated debate: is it a disrupted, d...
A fiery address from Palantir’s CEO has ignited a broader debate on how AI firms partner with the Pentagon and how po...
The debt tally has climbed to $39 trillion, with daily additions near $5 billion. Economists warn the path could cons...
As volatility persists in 2026, savvy investors are exploring the tax advantages of placing Main Street Capital in a ...
David Cordani is stepping aside as Cigna's CEO to become executive chairman, ending a 17‑year run that propelled the ...
Quantum computing stocks moved lower in Monday trading as investors rotated into safer assets amid a broader tech mar...
A notable stake in Magnite signals a contrarian take on the ad tech landscape. This article breaks down the move, wha...
NVIDIA guided higher-than-expected revenue for the coming quarter, but investors greeted the news with a muted respon...
A failing satellite firm pivoted by selling spectrum to SpaceX, triggering a sharp stock surge and turning investor b...